Cepheid Share Price

Stocks

01/12/01

15/17/15	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/16/05	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/16/27	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/16/24	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
06/16/06	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR

06/16/06	Danaher : renforce dans les diagnostics avec Cepheid
06/16/06	Danaher : acquiert le spécialiste des diagnostics Cepheid

Manager	Title	Age	Since
Charles Mwangi DFI	Director of Finance/CFO	59	01/07/2023
Anupama Mokkapati COO	Chief Operating Officer	-	01/11/2021
Laurent Bellon COO	Chief Operating Officer	-	01/08/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CEPHEID	-.--%	+0.36%	-	-	0
SARTORIUS AG	+3.78%	-6.32%	+16.38%	-40.50%	1.51TCr
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+1.77%	+9.42%	+3.64%	+97.22%	171.33Cr
QUIDELORTHO CORPORATION	-0.95%	+1.46%	-36.11%	-80.87%	114.77Cr
ECKERT & ZIEGLER SE	+1.71%	-3.11%	-36.77%	+12.77%	96Cr
CONTEC MEDICAL SYSTEMS CO.,LTD	+0.28%	-1.20%	-43.30%	-53.77%	63Cr
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+1.36%	-1.22%	-49.84%	-57.38%	51Cr
VAREX IMAGING CORPORATION	+1.37%	+3.82%	+40.89%	-51.71%	46Cr
REVENIO GROUP OYJ	+1.31%	-1.27%	-56.26%	-60.63%	37Cr
CELLAVISION AB	+1.83%	-2.96%	-19.69%	-33.15%	35Cr
Average	+1.25%	-1.69%	-20.12%	-29.78%	236.07Cr
Weighted average by Cap.	+2.98%	-6.92%	+5.43%	-30.45%